Navigation Links
Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits

n the development and commercialisation of drugs for pain control, sedation and other CNS disorders such as Parkinson's disease. The company is based in Cambridge, England. For further information visit the CeNeS web site: www.cenes.com

About M6G Morphine formulations are the gold standard treatment for the relief of moderate to severe post-operative pain. A limitation of morphine treatment is often the unpleasant side effects experienced, of which nausea and vomiting are the most common. PONV is rated among patients as one of the most distressing after-effects of surgery and reduces their quality of life.

The active potent metabolite of morphine, morphine-6-glucuronide (M6G), may offer therapeutic advantages over morphine in having an equivalent analgesic effect, but with a reduced tendency to cause nausea, vomiting and respiratory depression. Phase II and III clinical trials have shown that M6G given intravenously produces equivalent analgesia to morphine to combat post-operative pain. Studies have also shown that M6G reduced the incidence of nausea and vomiting when compared directly with morphine. Other studies published recently in the scientific literature demonstrate that M6G also reduces respiratory depression compared to morphine.

M6G022 Study Design

The study involved 24 centres in six European countries and recruited 517 patients. The study was designed primarily to provide key information on a comparison of effective intravenous pain management regimens of M6G or morphine treatment for a minimum of 24 hours (and up to 48 hours) following major abdominal surgery. Morphine is generally accepted as the "gold standard" drug for use in these circumstances. Initial pain management was achieved by administration of a loading dose and titration of either M6G or morphine to achieve acceptably low levels of pain for the patient to go onto the ward. In the ward, pain management treatme
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Molecular Target of Bradmers Neuradiab Further Validated by Independent Findings
3. Phase III Clinical Trial with 4-Month Long-Acting Formulation of Triptorelin: Ipsen Decides Not to Perform Further Administration
4. New Data on Market-Leading Velcade (Bortezomib) for Injection Further Strengthen Role in Previously Treated Multiple Myeloma
5. Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical Trial Data
6. MIV Therapeutics Announces Pivotal Test Results Further Validating Company Stent Coatings Meet Critical FDA Fatigue Guidelines
7. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
8. Medivations Dimebon Maintains Statistically Significant Benefit on All Five Efficacy Endpoints in Alzheimers Disease Trial After One Year of Therapy
9. Repros Androxal Shows Highly Statistically Significant Positive Effects in Men with Secondary Hypogonadism
10. Positive Statistical Analysis from Synthetic Bloods Oxycyte Traumatic Brain Injury Trial Indicates Achievement of Primary Endpoint
11. ISTA Pharmaceuticals Announces Statistically Significant Preliminary Results From its U.S. Phase II/III Clinical Study Of Bepotastine
Post Your Comments:
(Date:7/2/2015)... DUBLIN , June 26, 2015 ... of the "Vitamin D Market by Analog, Application, End-User ... report to their offering. This market is ... use of vitamin D in different applications and rising opportunities ... China , Italy , and ...
(Date:7/2/2015)... , July 2, 2015 Numotion,s Board ... Officer announced that Tamas Feitel has joined ... joins Numotion after a highly successful 18 year career ... roles driving strategy, profitability, and productivity to result in ... recent position was Chief Financial Officer for GE Healthcare ...
(Date:7/2/2015)... July 2, 2015 The report ... Heterofermentative), Species (Lactobacillus, Pediococcus & Enterococcus), Enzymes (Fibre-digesting & ... to 2020", Silage Inoculants & Enzymes Market is expected ... of 4.0% from 2015 to 2020. ... spread through 194 P ages and ...
Breaking Medicine Technology:Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 3Numotion Names Tamas Feitel Chief Financial Officer 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 4
(Date:7/5/2015)... ... 05, 2015 , ... Women’s Excellence in Wellness, powered by Movestrong ... The special consists of 2 months of unlimited classes for just $65. Student ID ... at 1410 South Lapeer Road in Lake Orion. , Women’s Excellence ...
(Date:7/4/2015)... , ... July 04, 2015 , ... Chronic Neck Pain. ... chronic pain sufferers have pain located in the neck. Another 19% suffer from head, ... Chiropractic literature suggests that 45% of American workers must deal with neck ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... ... for enrollment on July 2nd creating a buzz of media attention. In an ... published online by HonestyFirstReviews.com's Tiffany Hendricks. , "These days many people are feeling ...
(Date:7/3/2015)... ... July 03, 2015 , ... Renowned rhinoplasty surgeon ... the 2016 Dallas Rhinoplasty Symposium . To be held from March 4th - ... be held at the Westin Galleria Dallas. , Designed to take participants from the ...
(Date:7/3/2015)... ... July 03, 2015 , ... Smoothies are all the rage right ... and easily accessible, quality ingredients. Aurora Natural is proud to introduce a new line ... of fiber, protein, antioxidants, vitamins and minerals! , Aurora is offering a variety of ...
Breaking Medicine News(10 mins):Health News:New Advancement in Treatment of Chronic Neck Pain 2Health News:New Advancement in Treatment of Chronic Neck Pain 3Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 2Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 3Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2
... day of family skiing in Canada ended with actress Natasha Richardson hospitalized ... be the exception and not the rule, the American Academy of Orthopaedic ... while on the slopes., , ... surfaces those frigid temperatures can produce on the ski slopes , ...
... Award Dinner to Benefit Phoenix HouseThe Plaza, New York, March 30, ... the Grammy Award-winning musician, producer, and humanitarian, will join Fireman ... Paul Fireman , Dan Fireman, Shaquille O,Neal, Eli Manning , ... other stars from music, sports, and business to honor Lisa ...
... New Survey Suggests Parents Most Influence Teens, Decisions About SexWASHINGTON, ... States increased 1% in 2007, according to data released today ... is the second year in a row that the teen ... of continuous decline in the teen birth rate. That ...
... Finding could lead to new treatments for the disease, researchers ... genes that support replication of the hepatitis C virus (HCV) ... Hospital researchers. , They also found that blocking several ... may be a few years away from developing therapies based ...
... eyelid surgery were ranked the top 3 cosmetic surgery procedures in 2008 ... Plastic Surgery. The clinical results of New Jersey plastic surgeon , ... , ... Paramus, NJ (Vocus) March 19, 2009 -- Dr. Paul Parker, a ...
... School of Medicine has received a four-year, $4.7 million ... new ways to stop deadly hospital-acquired infections that often ... share of the national 2008-2009 tobacco settlement, will focus ... and the drug-resistant bacteria known as MRSA, which cause ...
Cached Medicine News:Health News:Media Alert: Tips on Skiing Safely From the American Academy of Orthopaedic Surgeons 2Health News:Wyclef Jean and Miri Ben-Ari to Lead Phoenix House Tribute to Lisa Ellis of Fireman Capital Partners and Carnival House Recordings 2Health News:Wyclef Jean and Miri Ben-Ari to Lead Phoenix House Tribute to Lisa Ellis of Fireman Capital Partners and Carnival House Recordings 3Health News:Teen Birth Rate Up For Second Year in a Row 2Health News:Progress Reported Against Gene Involved in Hepatitis C 2Health News:New Jersey Plastic Surgeon Helps Determine Top Cosmetic Surgery Procedures of 2008 2Health News:New Jersey Plastic Surgeon Helps Determine Top Cosmetic Surgery Procedures of 2008 3Health News:Pitt receives $4.7 million award to reduce hospital-acquired infections 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: